Clinical Trial
Published on 16 Sep 2024
Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 30-month analysis of the phase 3 ILLUMINATE-B trial
in Pediatric Nephrology
![Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 30-month analysis of the phase 3 ILLUMINATE-B trial](https://www.frontiersin.org/files/myhome article library/1392644/1392644_Thumb_400.jpg)
- 1,935 views
- 1 citation
Clinical Trial
Published on 16 Sep 2024
in Pediatric Nephrology
Systematic Review
Published on 22 May 2024
in Pediatric Nephrology
Original Research
Published on 02 May 2024
in Pediatric Nephrology
Review
Published on 11 Apr 2024
in Pediatric Nephrology
Editorial
Published on 10 Apr 2024
in Pediatric Nephrology
Original Research
Published on 23 Feb 2024
in Pediatric Nephrology
Brief Research Report
Published on 22 Feb 2024
in Pediatric Nephrology
Mini Review
Published on 15 Feb 2024
in Pediatric Nephrology
Case Report
Published on 16 Jan 2024
in Pediatric Nephrology
Original Research
Published on 16 Jan 2024
in Pediatric Nephrology
Case Report
Published on 05 Jan 2024
in Pediatric Nephrology
Perspective
Published on 07 Dec 2023
in Pediatric Nephrology
Case Report
Published on 23 Nov 2023
in Pediatric Nephrology
Review
Published on 10 Nov 2023
in Pediatric Nephrology
Case Report
Published on 10 Nov 2023
in Pediatric Nephrology
Case Report
Published on 01 Nov 2023
in Pediatric Nephrology